GGrantIndex
← Leaderboards

Lori Chaffin Jordan

Johns Hopkins University

$8,910,492
Attributed
$16,904,973
Total exposure
11
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY200825
$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,904,973 · 11

By mechanism

R01$13,522,833 · 6
U01$936,807 · 1
K23$884,409 · 1
U34$732,073 · 1
K24$547,252 · 1
R21$281,599 · 1

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Child

Research focus

ChildAdultStrokeCohortHigh RiskRisk FactorsPublic Health RelevanceMagnetic Resonance ImagingStroke PreventionBrainSickle Cell AnemiaImageChildhoodAffectCerebrovascular CirculationCerebral InfarctionEnrollmentHemodynamicsCerebrumNeuroimagingBrain ImagingInfarctionBloodBase

Grant awards (41)

Sleep Promoting Intervention to Improve Diabetes Outcomes and Executive Function in Adolescents with T1D$745,355
R01 · FY2025 · DK
Biomarkers of ischemic brain injury in adults with sickle cell disease$712,232
R01 · FY2025 · HL · contact PI
Neurocognitive Complications of Pediatric Type 1 Diabetes: Identifying Modifiable Risk and Protective Factors$617,580
U01 · FY2025 · DK
Personalized hemodynamic and metabolic signatures of revascularization response in moyamoya disease$576,014
R01 · FY2025 · NS
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$431,490
R01 · FY2025 · NS
Sleep Promoting Intervention to Improve Diabetes Outcomes and Executive Function in Adolescents with T1D$750,619
R01 · FY2024 · DK
Biomarkers of ischemic brain injury in adults with sickle cell disease$697,988
R01 · FY2024 · HL · contact PI
Personalized hemodynamic and metabolic signatures of revascularization response in moyamoya disease$594,764
R01 · FY2024 · NS
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$418,546
R01 · FY2024 · NS
Neurocognitive Complications of Pediatric Type 1 Diabetes: Identifying Modifiable Risk and Protective Factors$319,227
U01 · FY2024 · DK
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$134,374
R01 · FY2024 · NS
Biomarkers of ischemic brain injury in adults with sickle cell disease$712,232
R01 · FY2023 · HL · contact PI
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$436,309
R01 · FY2023 · NS
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$134,374
R01 · FY2023 · NS
Mentoring in Patient-Oriented Research focused on Neurological Complications of Sickle Cell Disease$108,544
K24 · FY2023 · HL · contact PI
Biomarkers of ischemic brain injury in adults with sickle cell disease$712,232
R01 · FY2022 · HL · contact PI
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$444,921
R01 · FY2022 · NS
Mentoring in Patient-Oriented Research focused on Neurological Complications of Sickle Cell Disease$108,544
K24 · FY2022 · HL · contact PI
Mentoring in Patient-Oriented Research focused on Neurological Complications of Sickle Cell Disease$108,544
K24 · FY2021 · HL · contact PI
Identifying Modifiable Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes$363,367
U34 · FY2020 · DK
MRI-based quantitative brain oxygen metabolism identifying high risk of infarct recurrence in sickle cell anemia$345,625
R01 · FY2020 · NS · contact PI
Mentoring in Patient-Oriented Research focused on Neurological Complications of Sickle Cell Disease$110,810
K24 · FY2020 · HL · contact PI
Primary prevention of stroke in children with SCD in Sub-Saharan Africa II$1,022,211
R01 · FY2019 · NS
Identifying Modifiable Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes$368,706
U34 · FY2019 · DK
MRI-based quantitative brain oxygen metabolism identifying high risk of infarct recurrence in sickle cell anemia$345,625
R01 · FY2019 · NS · contact PI
Mentoring in Patient-Oriented Research focused on Neurological Complications of Sickle Cell Disease$110,810
K24 · FY2019 · HL · contact PI
Primary prevention of stroke in children with SCD in Sub-Saharan Africa II$1,018,471
R01 · FY2018 · NS
MRI-based quantitative brain oxygen metabolism identifying high risk of infarct recurrence in sickle cell anemia$345,625
R01 · FY2018 · NS · contact PI
Primary prevention of stroke in children with SCD in Sub-Saharan Africa II$1,104,445
R01 · FY2017 · NS
MRI-based quantitative brain oxygen metabolism identifying high risk of infarct recurrence in sickle cell anemia$345,625
R01 · FY2017 · NS · contact PI
Primary prevention of stroke in children with SCD in Sub-Saharan Africa II$1,150,318
R01 · FY2016 · NS
MRI-based quantitative brain oxygen metabolism identifying high risk of infarct recurrence in sickle cell anemia$320,972
R01 · FY2016 · NS · contact PI
MRI-based quantitative brain oxygen metabolism identifying high risk of infarct recurrence in sickle cell anemia$22,466
R01 · FY2016 · NS · contact PI
Primary Prevention of Strokes in Nigerian Children with Sickle Cell Disease$134,855
R21 · FY2013 · NS
Predictors of recovery from intracerebral hemorrhage in children$177,012
K23 · FY2012 · NS · contact PI
Primary Prevention of Strokes in Nigerian Children with Sickle Cell Disease$146,744
R21 · FY2012 · NS
Predictors of recovery from intracerebral hemorrhage in children$119,205
K23 · FY2011 · NS · contact PI
Predictors of recovery from intracerebral hemorrhage in children$57,807
K23 · FY2011 · NS · contact PI
Predictors of recovery from intracerebral hemorrhage in children$177,012
K23 · FY2010 · NS · contact PI
Predictors of recovery from intracerebral hemorrhage in children$177,012
K23 · FY2009 · NS · contact PI
Predictors of recovery from intracerebral hemorrhage in children$176,361
K23 · FY2008 · NS · contact PI